Neurovascular Nuggets: Your Weekly Dose of Neurovascular Innovation

Neurovascular Nuggets: Your Weekly Dose of Neurovascular Innovation

by ossama mansour
Education

Neurovascular-Nuggets_ Unpacking AF Detection and Stroke Risk

Neurovascular-Nuggets (12) 🎁the key points from the article: - The study compared risk of recurrent stroke and outcomes between ECG-detected and prolonged cardiac monitoring (PCM)-detected atrial fibrillation (AF) in patients with ischemic stroke/TIA. - ECG-detected AF was associated with a 5-fold higher risk of recurrent ischemic stroke compared to PCM-detected AF, even after adjusting for anticoagulation use and other factors. - PCM-detected AF had lower cardiovascular risk profiles, better cardiac parameters, and lower stroke recurrence rates compared to ECG-detected AF. - PCM-detected AF burden was low, with median 5 hours duration and 2.23% burden over 14 days. Higher burden AF (>24 hrs) occurred in 29% of PCM-detected cases. - ECG-detected AF likely represents pre-existing, high burden AF compared to PCM-detected AF in stroke patients. 💡Clinical implications: - There is significant heterogeneity in thromboembolic risk between ECG-detected and PCM-detected AF after stroke/TIA. - ECG-detected AF should not be considered similar to PCM-detected AF and may warrant different clinical risk stratification. - PCM-detected AF still carries an important stroke recurrence risk that warrants anticoagulation, especially in higher burden AF. - Distinguishing between AF diagnostic types is important for prognosis and management of stroke patients with newly diagnosed AF. In summary, differentiating between ECG- and PCM-detected AF has implications for risk stratification and treatment decisions in stroke patients with newly diagnosed AF. Read more at hashtag#neurovascularnuggets https://lnkd.in/dFPFQfBA
Mar 26, 2026
10:26

Neurovascular Nuggets_ Unraveling Pediatric Circulatory Disorders

This is very important review that provides a comprehensive summary of mechanical cervicocerebral circulatory disorders in children, with several key implications: - It emphasizes that pediatric patterns differ substantially from adults for these conditions. For bow hunter's syndrome, pediatric cases primarily involve the upper cervical spine (C1-C2) with vertebral artery dissection, while adults more commonly have lower cervical disease related to spondylosis. - Recognition that bow hunter's syndrome is a major cause of posterior circulation stroke in children is critically important. Appropriate diagnosis with catheter angiography and head rotations is needed to guide surgical management and prevent recurrence. - The high rate of recurrent stroke with medical management alone found by Rollins et al (80% recurrence) highlights the need for definitive surgical treatment in pediatric bow hunter's syndrome. This differs from the lower recurrence rates with medical therapy in adults. - For Eagle's syndrome, the review highlights that symptomatic internal carotid artery compression or dissection is very rare in children compared to adults. However, diagnosis with provocative vascular imaging and surgical treatment principles are similar. - Growing evidence indicates symptomatic jugular venous compression can occur in children, causing headaches or cognitive issues. The entity is likely underdiagnosed currently. - Dynamic venography showing reversible flow changes or elevated gradients with head positioning is key to definitively diagnosing jugular compression syndromes. This differs from traditional thinking that venous drainage should not be posture-dependent. - The provided examples demonstrate how bony anatomical variants in children likely increase their risk for developing these disorders compared to adults. Recognition of high-risk anatomy on CT or MRI is important. - The review emphasizes that catheter angiography remains the gold standard for diagnosis of these disorders, as it provides the best combination of dynamic information and anatomical detail with head provocation maneuvers. Overall, the paper greatly improves understanding of how pediatric mechanical circulatory disturbances differ from adults. This will support prompt recognition and appropriate diagnosis and management in children presenting with concerning symptoms or posterior circulation events. Read more at hashtag#neurovascularnuggets https://lnkd.in/dKkCypyS
Mar 26, 2026
9:55

Neurovascular Nuggets_ The ENRICH Trial - A Turning Point for ICH Surgery

turning point in the nihilism surrounding surgery for ICH Based on my review, here are the key points about the results and findings: This article discusses the results of the ENRICH trial, which evaluated minimally invasive surgery plus thrombolysis (MIPS) compared to medical management for the treatment of spontaneous lobar intracerebral hemorrhage (ICH). The key findings are: The ENRICH trial met its primary endpoint, demonstrating that MIPS led to superior functional outcomes at 6 months compared to medical management alone in patients with lobar ICH. MIPS was associated with higher rates of hematoma evacuation and lower mortality compared to medical management. An adaptive trial design allowed early stopping of enrollment for patients with anterior basal ganglia ICH due to futility, limiting the conclusions to lobar ICH. Uncommon but methodologically sound features of the trial design included use of a utility-weighted mRS, Bayesian statistics, and an adaptive design. These results are a major breakthrough, providing the first robust evidence that surgical evacuation can improve outcomes in a select group of ICH patients. Prior large randomized trials showed no benefit of surgery over medical management. The success of ENRICH appears due to improved patient selection, surgical technique, and timing compared to prior studies. It parallels recent successes for endovascular thrombectomy in ischemic stroke. The findings will likely lead to an increased role for minimally invasive surgery in guidelines and clinical practice for lobar ICH meeting ENRICH criteria. Key outstanding questions remain regarding optimal patient selection, timing, and surgical techniques. Direct comparative effectiveness studies with other interventions like endoscopic evacuation are still needed. Implementation may be limited by resource availability, especially in lower income regions. Overall though, this trial represents an exciting turning point in the nihilism surrounding surgery for ICH. Read more at hashtag#neurovascularnuggets https://lnkd.in/d94Fdxgp
Mar 26, 2026
10:46

Neurovascular Nuggets_ Unpacking Intracranial Hypertension in CVT

Based on reviewing the paper , here are the key points about the results and findings: - The study found that 46% of patients with acute cerebral venous sinus thrombosis (CVT) had evidence of intracranial hypertension (IH), based on elevated CSF pressure, papilledema, or optic disc protrusion. - IH was associated with higher thrombus volume, thrombosis of the dominant transverse sinus, superior sagittal sinus (SSS) thrombosis alone or combined with transverse sinus, and more thrombosed segments when bilateral transverse sinus thrombosis was absent. - Thrombus volume had the strongest association with elevated CSF pressure on linear regression. Volumes over 4ml were associated with higher risk of IH. - Dominant transverse sinus thrombosis was the most influential predictor of IH based on multivariate analysis. - The authors conclude that large thrombus volume and thrombosis of strategic venous segments like the SSS and dominant transverse sinus are risk factors for IH in CVT patients. - These findings align with some previous studies showing associations between dominant transverse sinus thrombosis and IH. However, the importance of thrombus volume and extensive SSS thrombosis are novel findings. - The implications are that patients with high-risk features like large thrombus volume and strategic sinus occlusions may benefit from closer monitoring and evaluation for IH after a CVT diagnosis. This could prevent complications like vision loss. In summary, this study identified potential imaging markers to predict IH risk in CVT patients, which could guide clinical monitoring and management. The findings on thrombus volume are new and require further confirmation. Read more at hashtag#neurovascularnuggets https://lnkd.in/dQEHv4hg
Mar 26, 2026
8:03

Neurovascular-Nuggets (8)_ Flow Diversion for Compressive ICA Aneurysms – A Deep Dive

Flow diversion for compressive unruptured internal carotid artery aneurysms with neuro- ophthalmological symptoms: a systematic review and meta-analysis Results - 22 studies included, 594 patients treated with flow diverters for compressive ICA aneurysms - Pooled rates of symptom recovery: 47.4% complete, 74.5% improvement - Rates of transient worsening: 7.1%, permanent worsening: 4.9% - Isolated visual symptoms: 30.6% complete recovery, 56.6% improvement - Isolated oculomotor symptoms: 47.8% complete recovery, 78% improvement - Aneurysm complete occlusion rate: 68.6% - Morbidity rate: 5%, mortality rate: 3.9% Comparison to Previous Research - Recovery rates are comparable to previous meta-analyses on surgical clipping, coiling, and parent vessel occlusion for similar aneurysms - Morbidity and mortality rates are slightly higher than some previous studies like PUFS trial - Occlusion rates align with other flow diverter studies - Emphasizes importance of early treatment, improving chances of recovery 10-fold if treated within 1 month of symptom onset Applications - Provides evidence for flow diversion as a valid treatment option for compressive ICA aneurysms - Informs clinical decision-making and patient selection for flow diversion - Suggests early treatment is critical for best outcomes - Adds to knowledge of expected recovery rates, risks, and occlusion rates with this technique The results generally confirm flow diversion as an appropriate treatment for these aneurysms, though early intervention is key. The data help set expectations on likelihood of recovery and risks. This study adds a comprehensive analysis to the existing literature on flow diversion for this indication. Read more at hashtag#neurovascularnuggets https://lnkd.in/dYafDCcv
Mar 26, 2026
14:00

Neurovascular Nuggets_ Tenecteplase vs. Alteplase and the Thrombus Length Mystery

The study included 1865 patients treated with either tenecteplase (n=787) or alteplase (n=1078) before mechanical thrombectomy. - Overall, early recanalization (modified TICI 2b-3) occurred in 19.8% with tenecteplase and 18.5% with alteplase (OR 1.09, 95% CI 0.83-1.44, p=0.52). - There was no significant difference in early recanalization rates between tenecteplase and alteplase based on time from IVT to angiography (Figure 2) or occlusion site (ICA, proximal M1, distal M1, M2) (Figure 3). - However, there was an interaction between treatment and thrombus length (Figure 4). Tenecteplase was associated with higher early recanalization compared to alteplase for thrombi ≥10mm in length (OR 2.43, 95% CI 1.02-5.81, p=0.04). - The authors conclude that overall recanalization rates were similar between tenecteplase and alteplase, but tenecteplase may be more effective than alteplase for early recanalization of larger thrombi before thrombectomy. Compared to previous studies, the results are mixed: The overall early recanalization rates are similar to those reported for both tenecteplase (around 20%) and alteplase (around 20% with longer IVT-to-angiography times) in prior studies. However, some previous studies like EXTEND-IA TNK found higher recanalization with tenecteplase (22%) compared to alteplase (10%). The current study did not replicate this difference. The finding that tenecteplase leads to higher recanalization for larger thrombi is consistent with recent in vitro data, but inconsistent with one prior study using the clot burden score that suggested tenecteplase was more effective for smaller clots. So the results add to conflicting data on whether tenecteplase provides superior early recanalization compared to alteplase before thrombectomy. The interaction with thrombus length is a novel finding and suggests tenecteplase could have particular benefits for larger clots if confirmed. Overall, the study supports current guidelines which recommend tenecteplase over alteplase based on the totality of evidence, but does not definitively demonstrate superior recanalization, especially for smaller distal occlusions. Further randomized controlled trials may be needed to clarify if tenecteplase should be first-line over alteplase. Read more at hashtag#neurovascularnuggets
Mar 26, 2026
8:15

Neurovascular Nuggets_ Rivaroxaban for Cerebral Venous Thrombosis – Unpacking a Feasibility Trial

Study of Rivaroxaban for Cerebral Venous Thrombosis: A Randomized Controlled Feasibility Trial Comparing Anticoagulation With Rivaroxaban to Standard-of-Care in Symptomatic Cerebral Venous Thrombosis Here are the key points from the research article on rivaroxaban vs standard-of-care for cerebral venous thrombosis (CVT): - The study was a randomized controlled feasibility trial conducted at 12 Canadian centers comparing rivaroxaban to standard anticoagulation (warfarin or low molecular weight heparin) for CVT. - 55 participants were enrolled over 2.5 years. The recruitment rate was 21.3 participants per year, meeting feasibility targets. 57% of eligible patients consented to enroll. - Median age was 48 years and 66% were female. Median time from diagnosis to enrollment was 3 days. - One patient on rivaroxaban had a symptomatic intracranial hemorrhage by day 180 (primary safety outcome), compared to none in the control group. Rates of clinically relevant non-major bleeding and recurrent CVT were also numerically higher with rivaroxaban. - All patients had at least partial recanalization by day 180 on imaging. - Despite over 75% having functional independence at baseline per mRS scores, participants reported impairments in quality of life, mood, fatigue, headaches and cognition at enrollment. All patient-reported metrics improved by days 180 and 365. - The authors conclude that recruitment targets were met but consent rates were suboptimal. Early safety signals potentially favor standard anticoagulation but overall event rates were low. Patient-reported outcomes suggest CVT impacts well-being despite mild stroke severity. Larger trials are needed to confirm safety and optimize antithrombotic therapy. Read more at https://lnkd.in/d6aEiydK
Mar 26, 2026
10:14

Neurovascular-Nuggets (5)_ The Surprising Link Between Long Sleep and Stroke Risk

In an investigation into the cardiovascular health disparities among racially and ethnically diverse populations, the Northern Manhattan Study (NOMAS) examined the correlation between sleep duration and subclinical carotid atherosclerosis, a precursor to stroke. The study controlled for a range of sociodemographic and lifestyle variables. The results, based on 1,553 community-dwelling adults, revealed a pronounced association between long sleep duration (≥9 hours) and increased presence and area of carotid plaque, independent of other risk factors. Conversely, short sleep duration (<7 hours) and daytime sleepiness showed no significant correlation with carotid atherosclerosis markers. These findings suggest that extended sleep duration may serve as an independent risk factor for carotid atherosclerosis, thereby providing a potential mechanistic link between long sleep and elevated stroke risk. The paper also explores potential mechanisms linking sleep duration to carotid atherosclerosis. Long sleep has been correlated with metabolic imbalances, inflammatory markers, and certain behavioral risk factors, all of which are implicated in cardiovascular disease. Despite these observations, causality remains unclear. The study suggests that targeted interventions aimed at sleep duration could serve as a novel pathway to mitigate carotid atherosclerotic burden, although further research is needed to elucidate the underlying mechanisms. Read more at hashtag#neurovascularnuggets https://lnkd.in/dxmdspRG
Mar 26, 2026
10:17

Decoding Carotid Stent Design_ A Deep Dive into Embolization Risk

This study aimed to evaluate the influence of carotid stent design on the risk of embolization during carotid artery stenting. Specifically, the research contrasted the volume of embolized material caught by filters during the procedure, using stents of different designs, namely, open-cell stents (OCS), closed-cell stents (CCS), and micromesh stents (MMS). The study was retrospective and conducted on patients with asymptomatic carotid stenosis above 70%, who underwent carotid artery stenting in an Italian medical institution between 2010 and 2022. The main focus, or primary end point, was the ratio of particulate material-to-total filter area, known as the embolic filter debris (EFD) load. The secondary endpoints studied were 30-day major stroke and death rates. Results from 481 carotid artery stentings revealed that 35% used OCS, 14% used CCS, and 50% used MMS. The 30-day mortality and major stroke rate was low at 0.2%. Interestingly, the use of MMS resulted in the cleanest filters (41% free from embolized material), and had a lower EFD load compared to other stent designs. These findings remained consistent even after adjusting for plaque characteristics. In conclusion, micromesh stents seemed to be associated with a lessened embolization risk during carotid artery stenting, as evidenced by lower embolic filter debris load and more filters free from particulate matter. Nevertheless, further studies will be necessary to confirm these findings and potentially guide the choice of stent design in clinical practice. https://www.ahajournals.org/doi/10.1161/STROKEAHA.123.043117?fbclid=IwAR25o0dKZYcQ3jUu1QfQYF5vN4z4-1eZNy0PoDZ4kNZqDSTK5NNAs4WNcko_aem_AUsuUyz0w5Mxg2DeftDGbvclFpXMGjtUtewhrI7kK3F05PRr4TWYwArurR4uzLNbHaE
Mar 26, 2026
9:40
2 of 2